Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Introduction to the Special Issue: “Making orexin-based therapies for addiction a reality: What are the steps from here?”
Morgan H. James, Gary Aston‐Jones
Brain Research (2020) Vol. 1731, pp. 146665-146665
Open Access | Times Cited: 21

Showing 21 citing articles:

The hypocretin (orexin) system: from a neural circuitry perspective
Shi‐Bin Li, Luı́s de Lecea
Neuropharmacology (2020) Vol. 167, pp. 107993-107993
Closed Access | Times Cited: 111
Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?
Morgan H. James, Jennifer E. Fragale, R. Nisha Aurora, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 5, pp. 717-719
Open Access | Times Cited: 51
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Sleep dysregulation in binge eating disorder and “food addiction”: the orexin (hypocretin) system as a potential neurobiological link
Jacqueline B. Mehr, Deborah Mitchison, Hannah E. Bowrey, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2051-2061
Open Access | Times Cited: 46
Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction
Morgan H. James, Gary Aston‐Jones
Biological Psychiatry (2022) Vol. 92, Iss. 11, pp. 836-844
Open Access | Times Cited: 33
Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Chronic but not acute morphine exposure reversibly impairs spike generation and repetitive firing in a functionally distinct subpopulation of orexin neurons
Emma Berry, Ellen N. Huhulea, Masaru Ishibashi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
New directions in modelling dysregulated reward seeking for food and drugs
Robyn M. Brown, Christopher V. Dayas, Morgan H. James, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 1037-1048
Open Access | Times Cited: 23
Oxytocin and orexin systems bidirectionally regulate the ability of opioid cues to bias reward seeking
Giuseppe Giannotti, Francesca Mottarlini, Jasper A. Heinsbroek, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H. James, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial
Thomas C. Neylan, Anne Richards, Thomas J. Metzler, et al.
SLEEP (2020) Vol. 43, Iss. 10
Open Access | Times Cited: 22
The sensation seeking trait confers a dormant susceptibility to addiction that is revealed by intermittent cocaine self-administration in rats
Shayna L. O’Connor, Gary Aston‐Jones, Morgan H. James
Neuropharmacology (2021) Vol. 195, pp. 108566-108566
Open Access | Times Cited: 13
Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity
Jazmine D. W. Yaeger, Kevin T. Krupp, Jason J. Gale, et al.
Medicine in Drug Discovery (2020) Vol. 8, pp. 100059-100059
Open Access | Times Cited: 14
The dual orexin/hypocretin receptor antagonist suvorexant reduces addiction-like behaviors for the opioid fentanyl
Shayna L. O’Connor, Jennifer E. Fragale, Morgan H. James, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 12
Machine Learning Models to Predict Ligand Binding Affinity for the Orexin 1 Receptor
Vanessa Zhang, Shayna L. O’Connor, William J. Welsh, et al.
Artificial Intelligence Chemistry (2023) Vol. 2, Iss. 1, pp. 100040-100040
Open Access | Times Cited: 4
Emerging medications and pharmacological treatment approaches for substance use disorders
Joel S. Raymond, Anastasios Athanasopoulos, Connie J. Badolato, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 248, pp. 173952-173952
Open Access | Times Cited: 1
Recent advances in drug discovery efforts targeting the sigma 1 receptor system: Implications for novel medications designed to reduce excessive drug and food seeking
L. Knowles, Abanoub J. Armanious, Youyi Peng, et al.
Addiction Neuroscience (2023) Vol. 8, pp. 100126-100126
Open Access | Times Cited: 2
Orexins in Food and Addiction
Morgan H. James, Gary Aston‐Jones
Oxford University Press eBooks (2024), pp. 157-164
Closed Access
In vivo microdialysis reveals that blockade of accumbal orexin OX2 but not OX1 receptors enhances dopamine efflux in the nucleus accumbens of freely moving rats
Hiroki Kawashima, Yuri Aono, Yuriko Watanabe, et al.
European Journal of Neuroscience (2022) Vol. 55, Iss. 3, pp. 733-745
Closed Access | Times Cited: 2
Dual orexin receptor antagonist in treatment of insomnia
Nikola N. Trajanovic
Engrami (2020) Vol. 42, Iss. 2, pp. 57-68
Open Access
Page 1

Scroll to top